HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mylan launches review to unlock firm’s“true value”

This article was originally published in OTC Bulletin & The Rose Sheet

Executive Summary

Mylan has put together a board committee which is “actively evaluating a wide range of alternatives to unlock the true value of our one-of-a-kind platform”. Describing current “negative trends and dynamics” in the US as “unsustainable for the US healthcare system”, Mylan insisted investors “under-appreciate and under-value the durability, differentiation and strengths of Mylan’s global diversified business”.


Related Content

Aspen And Mylan Strike A Deal On Australia And New Zealand Portfolio





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts